ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
Na Li(Beijing Forestry University), Tariq M. Rana(University of California San Diego), Sarah Huff(University of California San Diego), Yinsheng Wang(University of California, Riverside), Gwendolyn González(University of California, Riverside), Sandip Pravin Patel(University of California San Diego), Yuqi Kang(University of California San Diego), Lingling Wang(Shandong University of Traditional Chinese Medicine), Kriti Agrawal(University of California San Diego), Hui Hui(University of California San Diego), R. Tang(University of California San Diego)
Cited by 595
Related Papers
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
|Molecular Cancer Therapeutics|2015|2.3k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancerdiagnostic approach
|Nature|2020|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k